To assess the effectiveness of medicine on non-obstructive azoospermia (NOA).
Treatment
Andriol and tamoxifen were used for idiopathic NOA while aescuven forte and aspirin used for NOA with varicocele (including two varicocelectomy). The time was four months.
Results
Of the 32 patients, 13 underwent testicular biopsy, pathological results showed six patients (46 per cent) with hypospermatogenesis, five patients (39 per cent) with maturation arrest, and two patients (15 per cent) with sertoli cell syndrome. Nine patients (28 per cent) had varicocele; two patients (6 per cent) underwent surgical treatment. After treatment, sperm was detected in 20 patients (63 per cent), seven of them (22 per cent) had detectable sperm in semen after one month of treatment; five (19 per cent) had sperm after two months of treatment; eight (25 per cent) had sperm after three months of treatment. Among the 23 patients with idiopathic azoospermia, 13 patients had detectable sperm in semen after treatment (56 per cent). The level of hormone gradually increased in 15 patients, rapidly increased in four patients, but four patients had no obvious change of hormone level. Among the nine patients with varicocele, three persons (including one patient undergoing surgery) had normal sperm density after 3-4 months of treatment, continuing the treatment for another 2-3 months, wife of the patients gained pregnancies. After treatment, seven patients had gradually decreasing serum level of FSH, LH and T while two patients had increased serum level of hormones. Excluding the three pregnancy patients, it was showed that the sperm density increased (t=-3.342, p=0.004) after treatment, so did the forward moving sperm ratio (t=-4.037, p=0.001), but semen volume had no significant changes (t=-1.698, p=0.109).
Conclusion
The treatment of varococele is important for the NOA with varicocele while andriol and tamoxifen is other method for the treatment of idiopathic NOA.
to direct toward causes such as varicocele.
What new information is offered in this study?
It is maybe not androgen but estrogen which effects the expression of FSH.
What are the implications for research, policy, or practice?
There is urgent to known the effectiveness of reproductive hormone on spermatogenesis which is maybe different with the traditional concept.
Background
With the development of reproductive medicine, most patients can achieve the ability of birth through assisted reproductive technology (ART). But Non-obstructive azoospermia (NOA) is still a problem in the field of ART. Although the disease incidence is not high, 1 Evaluation criteria: If sperm was detected in semen for more than two consecutive times, the treatment was considered effective and was included into the statistical analysis.
Statistics: SPSS18.0 was used for analysis; paired t test was used for comparison between two groups. p≤0.01 indicated statistical significance.
Results
Of the 32 patients, 13 underwent testicular biopsy, pathological results showed six patients with hypospermatogenesis (46 per cent), five patients with maturation arrest (39 per cent), and two patients with sertoli cell syndrome (15 per cent). Nine patients had varicocele (28 per cent); two patients underwent surgical treatment (6 per cent). After treatment, sperm was detected in 20 patients (63 per cent), seven of them (22 per cent) had detectable sperm in semen after one month of treatment; five (19 per cent) had sperm after two months of treatment; eight (25 per cent) had sperm after three months of treatment (Table 1) . Among the 23 patients with idiopathic azoospermia, 13 patients had detectable sperm in semen after treatment (56 per cent). The level of hormone gradually increased in 15 patients, rapidly increased in four patients, but four patients had no obvious change of hormone level.
Among the nine patients with varicocele, seven patients had detectable sperm in semen after treatment (77 per cent). Among them, three (including one patient undergoing surgery) had normal sperm density after 3-4 months of treatment, continuing the treatment for another 2-3 months, wife of the patients gained pregnancies. After treatment, seven patients had gradually decreasing serum level of FSH, LH and T while two patients had increased serum level of hormones; the reason needs to be discussed in the nest time.
After excluding the three pregnancy patients, we found that the sperm density increased (t=-3.342, p=0.004) after treatment, so did the forward moving sperm ratio (t=-4.037, p=0.001), but semen volume had no significant changes (t=-1.698, p=0.109) ( Table 2 ). Among the nine NOA with varicocele, seven patients had detectable sperm in semen after treatment (77 per cent). Among them, three (including one patient undergoing surgery) had normal sperm density after 3-4 months of treatment, pregnancies occurred after another 2-3 months of treatment. After treatment, seven patients had gradually decreasing serum level of FSH, LH and T, and two patients had increased serum level of hormones. Aescuven forte is produced by Cesra Arzneimittel GmbH & Co.KG, it can improve the venous return and venous function, 8 and is currently widely used in venous disease. 8, 9 In this study, decreased levels of sex hormones may be the result of a recovery of testicular function after the improvement of venous return. But why some patients had increased level of FSH and LH after treatment remains to be investigated.
Although treatment of varicocele is controversial, 10 we observed that good surgical treatment or drug treatment could achieve good therapeutic effect for varicocele patients with NOA.
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Conclusion
For NOA patients, varicocele is still an important factor that needs more attention, using surgery or drug treatment may make patients gradually restore spermatogenic function. For idiopathic NOA patients, tamoxifen -testosterone undecanoate is a good treatment.
